Articles
Featured Articles
Read our latest stories on the people and scientific innovations making a difference in patients’ lives.
Programs & Initiatives
Bridging Global Gaps in Hemophilia Care
Pfizer is proud of its commitment to advancing hemophilia care for more than 40 years, dating back to the introduction of recombinant therapies. But while there has been transformative progress as well as advances in the hemophilia treatment landscape during this time, there is still work to be done to ensure more patients receive the best care.Collaboration is an essential component of our efforts to increase access to treatment and bring breakthroughs to people with hemophilia and bleeding...
Science & Innovation
The Next Era of Decentralized Clinical Trials: The Clinical Trial Anywhere Model
During the early months of 2020, decentralized modalities to conduct clinical trials went mainstream as a solution to a short-term problem: how to continue clinical trials amid pandemic closures. At Pfizer, however, remote trials and the use of digital tools to conduct clinical trials were implemented long before the pandemic. Increased adoption of modalities like telehealth visits became catalysts for how — and where — clinical research could be done.What's more, surveys show that participants...
Science & Innovation
Harnessing the Power of AI to Detect ATTR-CM
Artificial intelligence (AI) has quietly become a part of our daily lives – through personalized recommendations, virtual assistants, or smart devices, we barely notice it anymore. Yet many of us might not realize the advances AI is making in healthcare. From accelerating drug discovery to improving disease detection, it is transforming the way we understand and manage health.AI has had numerous applications in cardiology in recent years, from analyzing results of cardiac imaging tests to...
Science & Innovation
In Search of a New Hemophilia Treatment
Despite significant advancements in hemophilia treatments over the past several decades, a fundamental challenge remains for many patients: balancing management of the disorder while maintaining regular day-to-day activities.Historically, treatments could be cumbersome and time-consuming to administer. They typically required intravenous administration up to several times a week to prevent bleeding episodes.1 Even treatments that could be administered at home required infusions multiple times a...
Science & Innovation
Viral vs Bacterial Infections: Different Pathogens, Different Approaches
When you experience symptoms of an infection such as fever, fatigue, decreased appetite, or pain, knowing whether a virus or bacteria is making you sick may be the key to getting the right treatment and feeling better.1,2Viruses and bacteria are among the most well-known causes of infection.3 Infections occur when viruses or bacteria invade the human host and proliferate.3 But there are some important distinctions between them, and it’s important to determine whether it’s a bacteria or virus...
Science & Innovation
Pharma Peers Unite to Build DNA-Encoded Libraries
Finding tools and hits for targets in drug discovery can feel like hunting for four leaf clovers in a blizzard. And researcher Sylvie Sakata was close to giving up on one discovery tool, DNA-encoded libraries, when a new consortium started to fall into place. Now this technology is garnering more interest for its potential to discover new molecular compounds, known as “hits,” to exponentially impact the early research efforts that can lead to potential new medicines.Sakata is the Head of...
Science & Innovation
What You Need to Know About a Promising Vaccine Candidate that May Stem the Growing Risk of Lyme Disease
Lyme disease is the most common vector-borne illness in the United States.1 The U.S. Centers for Disease Control and Prevention (CDC) says that state health departments reported over 63,000 cases in 2022.2 However, the CDC uses other methods to estimate that approximately 476,000 people in the U.S. may be diagnosed and treated for Lyme disease annually.2In other words, the estimated number of Lyme disease cases in the U.S. seems to be much higher than what is being reported to public health...
Living & Wellbeing
Caregiver Support: A Guide to Self-Care for Caregivers
A mother helps her daughter through dialysis at night and goes to work without sleep.1 A wife cares for her husband as he spends 110 days recovering from treatment for acute myeloid leukemia in a hospital 250 miles from home.2 A son quits his job to support his mother after she suffers a series of strokes.3Each caregiver’s story is different, but their combined efforts serve as a lifeline to millions of people. Caregivers support children, parents, grandparents, family members, spouses...
Science & Innovation
A New Road to Migraine Relief
Migraine, a debilitating neurological disorder,1 affects over a billion people globally.2,3 The cause of migraine remains an active area of research–experts believe genetics, the nervous system, and the brain's blood vessels are involved in the condition.4,5 The majority of people have episodic migraine, experiencing between 0-14 days of headache per month.6 On the other hand, those with chronic migraine experience 15 or more days of headaches a month, with at least 8 of those days caused by...
Purpose & Ideals
Global Health Fellows: Partnering to Strengthen Health Systems
Recently, Ellen Gerstein, Pfizer's Senior Director of Digital Communications, visited Africa as part of our Global Fellows Program. She shares her experience in this article.At Pfizer, we’re driven by our Purpose—to deliver breakthroughs that change patients’ lives. That Purpose has never been more clear to me than during my experience partnering with North Star Alliance through Global Health Fellows—Pfizer’s signature skills-based volunteering program.Since 2003, Global Health Fellows has...
Purpose & Ideals
Clinical Trial Innovation: Putting the Patient First in Clinical Trial Design
Every day, across the United States and around the world, scientists are developing potential new medicines and vaccines that could change lives. But to get medicines and vaccines to the patients who need them most, they must first undergo a clinical trial, which is a research study that seeks to understand how potential medicines and other medical treatments work.These studies depend on the generosity of participants, who volunteer to be a part of the trial. Depending on the type of trial...
Living & Wellbeing
How Climate Change is Affecting the Spread of Lyme Disease—and 5 Things You Need to Know About the Disease
As the weather gets warmer, many of us will be spending more time outside, indulging in our favorite summer activities—and exposing ourselves to the elements, including a booming tick population. The incidence of Lyme disease has more than doubled over the last 24 years1 because populations of disease-carrying Ixodes ticks, better known as black-legged or deer ticks, have increased and expanded their ranges.2You don’t need to cancel summer adventures, but understanding ticks, the impact of...
Media Resources & Contact Information
Anyone may view our press releases, press statements, and press kits. However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer Media Contacts may only respond to calls and emails from professional journalists.